Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 3852

Original article / research
Table of Contents - Year : 2016 | Month : October | Volume : 10 | Issue : 10 | Page : EC05 - EC09

Immunohistochemical Evaluation of Role of Serotonin in Pathogenesis of Psoriasis EC05-EC09

Sheren Fouad Younes, Ola Ahmed Bakry

Correspondence
Dr. Sheren Fouad Younes,
Department of Pathology, Faculty of Medicine, Menoufia University, Shebeen El Koum, Menoufia, Egypt.
E-mail: sheren.younes@gmail.com

Introduction: Psoriasis is a common skin disorder characterized by erythaematosquamous papules and plaques. It is known to be associated with stressful and depressive disorders. Serotonin is a neurotransmitter that plays a role in the pathogenesis of inflammatory skin disorders.

Aim: To evaluate the role of serotonin in pathogenesis of psoriasis.

Materials and Methods: Using standard immunohistochemical techniques, 24 biopsies from patients with chronic plaque psoriasis were examined together with 12 biopsies from age and gender-matched healthy subjects as a control group.

Results: Both the percentage of positive cells (p=0.018) and H-score values (p=0.015) of serotonin expression were significantly higher in psoriasis compared to normal skin. H score of serotonin expression was significantly higher in cases with totally absent Granular Cell Layer (GCL) as opposed to those with thin/focally absent GCL (p=0.011), and in cases with moderate/strong epidermal inflammation compared to cases with mild inflammation (p=0.035). No significant correlation was detected between H score of cases and age, disease duration or Psoriasis Area and Severity Index (PASI) score.

Conclusion: Serotonin might play a role in development of psoriasis through its role as a growth factor promoting keratinocyte proliferation, and as mediator of inflammation and stimulant of T cell activation. It recruits T cells to sites of cutaneous inflammation and potentiate macrophage accessory function for T cell activation. Its expression is not related to the disease severity. Future large-scaled research on population of different ethnicities including other disease variants is needed. The use of serotonin receptor antagonists and serotonin reuptake inhibitors may be evaluated on wide-based studies to put the current observation into action.